Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16447201 | 0.98 | USP2 (0.40) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL2094040 | 0.98 | USP2 (0.40) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL2284853 | 0.98 | USP2 (0.40) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL3730156 | 0.97 | USP2 (0.37) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL30361807 | 0.93 | USP2 (0.37) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL28609548 | 0.85 | USP2 (0.31) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL29198910 | 0.82 | — | — | |
| SCHEMBL5497063 | 0.78 | USP2 (0.44) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL29973085 | 0.71 | CYP2C19 (0.42) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL3345554 | 0.71 | CYP2C19 (0.58) | USP2ALDH1A1LMNACYP1A2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 197 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1861043-B1 | DEVICE AND SYSTEM FOR AIDING VALVE ANNULOPLASTY | MEDTRONIC VASCULAR INC (US) | 2019-08-07 | — | — | EP | claimed |
| US-9101669-B2 | Self-assembed conjugate and use thereof | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2015-08-11 | — | — | US | claimed |
| US-20130195751-A1 | SELF-ASSEMBED CONJUGATE AND USE THEREOF | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2013-08-01 | — | — | US | claimed |
| US-20130136697-A1 | INJECTABLE DENDRIMER HYDROGEL NANOPARTICLES | NATIONAL INSTITUTES OF HEALTH (US) | 2013-05-30 | — | — | US | claimed |
| EP-2552458-A1 | INJECTABLE DENDRIMER HYDROGEL NANOPARTICLES | Wayne State University (US) | 2013-02-06 | — | — | EP | claimed |
| WO-2011123591-A1 | INJECTABLE DENDRIMER HYDROGEL NANOPARTICLES | WAYNE STATE UNIVERSITY (US) | 2011-10-06 | — | — | WO | claimed |
| US-7955385-B2 | Device, system, and method for aiding valve annuloplasty | MEDTRONIC VASCULAR, INC. (US) | 2011-06-07 | — | — | US | claimed |
| EP-1861043-A1 | DEVICE, SYSTEM, AND METHOD FOR AIDING VALVE ANNULOPLASTY | Medtronic Vascular, Inc. (US) | 2007-12-05 | — | — | EP | claimed |
| US-20070238979-A1 | Reference Devices for Placement in Heart Structures for Visualization During Heart Valve Procedures | MEDTRONIC VASCULAR, INC. (US) | 2007-10-11 | — | — | US | claimed |
| WO-2006093656-A1 | DEVICE, SYSTEM, AND METHOD FOR AIDING VALVE ANNULOPLASTY | MEDTRONIC VASCULAR, INC. (US) | 2006-09-08 | — | — | WO | claimed |
| US-20060195134-A1 | Device, system, and method for aiding valve annuloplasty | MEDTRONIC VASCULAR, INC. (US) | 2006-08-31 | — | — | US | claimed |
| EP-3998336-B1 | MICROORGANISMS AND METHODS FOR PRODUCING CANNABINOIDS AND CANNABINOID DERIVATIVES | UNIV CALIFORNIA (US) | 2026-01-07 | — | — | EP | disclosed |
| US-12460185-B2 | Optimized cannabinoid synthase polypeptides | DEMETRIX, INC. (US) | 2025-11-04 | — | — | US | disclosed |
| US-12215327-B2 | Microorganisms and methods for producing cannabinoids and cannabinoid derivatives | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-02-04 | — | — | US | disclosed |
| US-12048710-B2 | Compositions and methods for modification of biomolecules | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-07-30 | — | — | US | disclosed |
| EP-1812031-A2 | COMPOSITIONS AND METHODS FOR MODIFICATION OF BIOMOLECULES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-08-01 | — | — | EP | disclosed |
| WO-2006093656-A1 | DEVICE, SYSTEM, AND METHOD FOR AIDING VALVE ANNULOPLASTY | MEDTRONIC VASCULAR, INC. (US) | 2006-09-08 | — | — | WO | disclosed |
| US-20060195134-A1 | Device, system, and method for aiding valve annuloplasty | MEDTRONIC VASCULAR, INC. (US) | 2006-08-31 | — | — | US | disclosed |
| US-20060110782-A1 | cycloalkyne compounds reacting with an azide moiety on a target biomolecule, by biochemical conjugation; for its application in vivo (on the cell surface or intracellularly) or in vitro (synthesis of peptides); labeling | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2006-05-25 | — | — | US | disclosed |
| WO-2006050262-A2 | COMPOSITIONS AND METHODS FOR MODIFICATION OF BIOMOLECULES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2006-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12048710-B2 | Compositions and methods for modification of biomolecules | PTMS, QPCT, ANPEP | USP2 2277/4885ALDH1A1 3718/4885LMNA 1871/4885 |
| US-12215327-B2 | Microorganisms and methods for producing cannabinoids and cannabinoid derivatives | CNR2, CNR1, FAAH | USP2 2485/4885ALDH1A1 2306/4885LMNA 4339/4885 |
| US-20130136697-A1 | INJECTABLE DENDRIMER HYDROGEL NANOPARTICLES | UACA, PAM, JAK3 | USP2 864/4885ALDH1A1 1369/4885LMNA 3370/4885 |
| US-20060110782-A1 | cycloalkyne compounds reacting with an azide moiety on a target biomolecule, by biochemical conjugation; for its application in vivo (on the cell surface or intracellularly) or in vitro (synthesis of peptides); labeling | PTMS, QPCT, DNPEP | USP2 2504/4885ALDH1A1 3269/4885LMNA 3610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.